Skip to evidence report

MAC.MDM.complement_resolving: Studies — page 2

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,931 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1,001–2,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for MAC.MDM.complement_resolving
#Trait / studyIndividual trait IDMean IC score
1001LGALS8/TXNDC5 ratioGCST9031532115.68
1002Cholesteryl Esters in Large HDLGCST9049775115.65
1003Cholesterol in Large HDLGCST9049770915.62
1004Polyunsaturated fatty acid levelsGCST9050260615.62
1005Total lipids in VLDL (UKB data field 23424)GCST9026952115.57
1006Multi-trait sex scoreGCST9027011815.56
1007Triglycerides in small HDL (UKB data field 23578)GCST9026967515.56
1008SPARC/TACC3 ratioGCST9031587215.55
1009CERT/MAX ratioGCST9031402815.55
1010Phospholipids to Total Lipids in Very Large VLDL percentageGCST9050065515.54
1011TGFA levelsGCST9047084215.50
1012S100P levelsGCST9047052015.50
1013Other noninfective gastroenteritis and colitisFING0000107715.49
1014FKBP7 levelsGCST9046924515.49
1015Bipolar and major depression status - No Bipolar or Depression | Mental healthUKBB0000009415.49
1016CST7 levelsGCST9046889715.48
1017Cucumber likingGCST9009474915.47
1018CCL17/F2R ratioGCST9031368615.47
1019GLB1/PCSK9 ratioGCST9031493315.43
1020Monounsaturated fatty acids to total fatty acids percentageGCST9050237215.43
1021Free cholesterol in large LDLGCST9049798115.40
1022Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST9050056515.40
1023Phenylalanine levelsGCST9049922315.40
1024Cholesterol to total lipids ratio in large LDLGCST9009285715.38
1025Phospholipids to total lipids ratio in very large HDLGCST9009301315.37
1026GSTA1/SULT2A1 ratioGCST9031499615.36
1027Monounsaturated fatty acids to total fatty acids percentageGCST9050237315.34
1028IDP dMRI TBSS ICVF Sagittal stratum LGCST9000435815.32
1029Linoleic acid levelsGCST9050231115.32
1030wg rh intensity-contrast entorhinalGCST9000383215.29
1031Phospholipids in medium HDL (UKB data field 23567)GCST9026966415.29
1032Chronic iridocyclitisFING0000028715.24
1033IDP dMRI TBSS FA Cingulum cingulate gyrus RGCST9000391115.24
1034Cholesteryl ester levels in very large VLDLGCST9009301815.24
1035HTRA2/SIAE ratioGCST9031509715.23
1036Monounsaturated fatty acids levels (UKB data field 23447)GCST9026954415.23
1037Total fatty acid levelsGCST9050272715.22
1038Triglycerides to total lipids ratio in large HDLGCST9009285515.21
1039DIABLO/VSIR ratioGCST9031447015.21
1040CCL14 levelsGCST9046856615.19
1041Monounsaturated fatty acids to total fatty acids percentageGCST9050238415.19
1042Divergent concomitant strabismusFING0000047015.18
1043ST3GAL1 levelsGCST9047075215.18
1044DIPK2B levelsGCST9046899615.18
1045CST3/CTSZ ratioGCST9031429015.17
1046Cholesterol levels in chylomicrons and extremely large VLDLGCST9050090515.15
1047white blood cell count (WBC, mean, inv-norm transformed)GCST9047645415.14
1048Total lipid levels in chylomicrons and extremely large VLDLGCST9050099415.13
1049HGF/MMP8 ratioGCST9031505515.13
1050Cholesteryl esters in large VLDL (UKB data field 23499)GCST9026959615.13
1051Monounsaturated fatty acid levelsGCST9049909015.12
1052Crohn's diseaseGCST00413215.12
1053DKK1 levelsGCST9001206015.12
1054Cholesterol levels in chylomicrons and extremely large VLDLGCST9009304015.11
1055Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST9049816215.08
1056Monounsaturated fatty acids to total fatty acids percentageGCST9050204915.07
1057CD84/SORT1 ratioGCST9031391815.06
1058Cholesterol to total lipids ratio in medium HDLGCST9009289315.05
1059Polyunsaturated fatty acids to total fatty acids percentageGCST9050218115.05
1060Phospholipids in small VLDLGCST9049988115.04
1061LGALS9/SIGLEC1 ratioGCST9031532315.04
1062Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST9050094915.03
1063Omega-3 fatty acid levelsGCST9050206215.03
1064VSNL1 levelsGCST9047105415.02
1065DUT levelsGCST9046905415.02
1066CD274/EFNA4 ratioGCST9031376815.00
1067Cholesterol to Total Lipids in Large VLDL percentageGCST9049813015.00
1068MPO levelsGCST9046993714.98
1069PAPPA levelsGCST9047015714.97
1070CCL8 levelsGCST9046858614.95
1071Cholesterol to Total Lipids in Large VLDL percentageGCST9049812514.94
1072LGMN levelsGCST9046976614.90
1073rfMRI amplitudes (ICA100 node 15)GCST9000460314.90
1074Phospholipid levels in chylomicrons and extremely large VLDLGCST9050103114.89
1075triglyceride (minimum, inv-norm transformed)GCST9047643914.88
1076ANXA3/ANXA4 ratioGCST9031327814.86
1077APOM levelsGCST9046834214.84
1078GSR levelsGCST9046941014.83
1079DCXR/GSTA1 ratioGCST9031443714.83
1080MSRA/P4HB ratioGCST9031549514.83
1081CD69/PLXNA4 ratioGCST9031388014.81
1082C9 levelsGCST9046850514.81
1083Recent feelings or nervousness or anxiety | AnxietyUKBB0000074114.80
1084DBH levelsGCST9046894814.80
1085CCN2/ENO2 ratioGCST9031371214.80
1086Cholesteryl Esters in Medium LDLGCST9049873814.79
1087DAG1/MGLL ratioGCST9031437714.78
1088Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636)GCST9026973314.78
1089PCDH17 levelsGCST9047016914.77
1090Omega-3 fatty acids to total fatty acids percentageGCST9050208714.76
1091F-cake/biscuits liking (derived food-liking factor)GCST9009472214.74
1092IFNGR2 levelsGCST9046951414.74
1093CD244/TREML2 ratioGCST9031376714.73
1094Triglycerides to total lipids in large HDL percentage (UKB data field 23638)GCST9026973514.73
1095Cholesteryl Esters to Total Lipids in Small LDL percentageGCST9049959514.73
1096Concentration of small VLDL particlesGCST9049985614.72
1097Omega-6 fatty acid levelsGCST9050210314.71
1098Linoleic acid levelsGCST9050201214.70
1099Triglycerides in small LDL (UKB data field 23550)GCST9026964714.70
1100ACHE levelsGCST9046819914.69
1101ENO2/HCLS1 ratioGCST9031466014.69
1102CLTA levelsGCST9046879114.68
1103Free cholesterol in small VLDLGCST9049980814.67
1104Free cholesterol to total lipids ratio in large HDLGCST9009284914.65
1105Cholesterol levels in very large HDLGCST9050031014.62
1106Triglycerides in VLDLGCST9050029514.61
1107Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST9050059314.61
1108HNMT levelsGCST9046946814.59
1109FCER2/TREML2 ratioGCST9031479214.57
1110PLIN3/TYMP ratioGCST9031567814.57
1111Cholesteryl esters to total lipids ratio in large HDLGCST9009284714.55
1112COL3A1 levelsGCST9046881714.54
1113IDP dMRI TBSS ICVF Posterior limb of internal capsule RGCST9000434514.54
1114Phosphatidylcholine levelsGCST9049924014.53
1115HGF/MMP9 ratioGCST9031505614.52
1116Degree of unsaturationGCST9050274914.52
1117RGMB/SMOC2 ratioGCST9031577014.52
1118HYAL1 levelsGCST9046949514.51
1119aparc-a2009s rh area S-oc-middle+LunatusGCST9000342714.50
1120CLEC1A/CLEC7A ratioGCST9031408314.49
1121Ulcerative colitis, NASFING0000139014.48
1122Degree of unsaturationGCST9050016214.48
1123Triglyceride levels in chylomicrons and extremely large VLDLGCST9050107514.48
1124high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)GCST9047534814.46
1125APOBR levelsGCST9046833414.43
1126DSCAM levelsGCST9046904114.43
1127Cholesterol to Total Lipids in Very Large VLDL percentageGCST9050053914.40
1128T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80)GCST9032064314.39
1129Triglycerides to total lipids in small HDL percentage (UKB data field 23648)GCST9026974514.39
1130FIS1/HSPA1A ratioGCST9031482514.37
1131CD300C/GOLM2 ratioGCST9031378814.35
1132Parkinson's disease or first degree relation to individual with Parkinson's diseaseGCST00932514.33
1133Total lipids in small VLDLGCST9049984014.33
1134CD164/SIAE ratioGCST9031374414.30
1135FUT3_FUT5/LILRA2 ratioGCST9031488914.28
1136DCTPP1 levelsGCST9046896114.25
1137CASP8/DDX58 ratioGCST9031365114.25
1138Total Lipids in VLDLGCST9050023614.25
1139Cardiac pacemaker in situ (PheCode 426.91)GCST9047596014.24
1140Total lipid levels in VLDLGCST9009299914.22
1141CLEC4G/SEMA3F ratioGCST9031412314.21
1142CANT1 levelsGCST9046853614.20
1143Type 2 diabetesGCST00541314.20
1144Omega-6 fatty acids to total fatty acids percentageGCST9050212914.15
1145CD164 levelsGCST9046860214.15
1146MYOC levelsGCST9046998314.15
1147ADH1B levelsGCST9046824314.14
1148SEMA7A levelsGCST9047057514.14
1149ITGB1 levelsGCST9046964314.13
1150Triglyceride levels in medium LDLGCST9009291414.12
1151Phospholipids to Total Lipids in Very Small VLDL percentageGCST9050086614.09
1152CD84/VASH1 ratioGCST9031392014.09
1153Free cholesterol in large LDLGCST9049798714.07
1154ALCAM levelsGCST9046827914.05
1155CST3/RETN ratioGCST9031429714.03
1156NOTCH2 levelsGCST9047006614.03
1157CCL17/CD69 ratioGCST9031368414.02
1158Cholesterol to Total Lipids in Very Large VLDL percentageGCST9050054214.01
1159Cholesterol to Total Lipids in Very Small VLDL percentageGCST9050071613.98
1160VSTM1 levelsGCST9047105513.98
1161CD40/IGSF8 ratioGCST9031381513.97
1162Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB0000062513.96
1163NPL levelsGCST9047007213.95
1164ADH4/RBP5 ratioGCST9031319413.94
1165CCL13 levelsGCST9046856513.92
1166Concentration of chylomicrons and extremely large VLDL particlesGCST9009304713.92
1167CXCL17/SFTPA2 ratioGCST9031434113.91
1168severe traumatic brain injury, does not include concussionFING0000130013.91
1169DKK1/VASH1 ratioGCST9031448213.89
1170Docosahexaenoic acid levelsGCST9050197813.89
1171LBR/PSRC1 ratioGCST9031530013.89
1172TMPRSS5 levelsGCST9047089313.88
1173Other Crohn's diseaseFING0000099213.88
1174Cholesteryl Esters to Total Lipids in Small VLDL percentageGCST9049980013.87
1175Triglycerides in IDLGCST9049766113.84
1176MEGF9 levelsGCST9046988413.83
1177Monounsaturated fatty acids to total fatty acids percentageGCST9050204313.81
1178HGF/PLAUR ratioGCST9031505913.81
1179GLOD4/HSPA1A ratioGCST9031493713.81
1180Polyunsaturated fatty acid levelsGCST9049926613.80
1181ALDH1A1/CA3 ratioGCST9031324413.78
1182PTPRB levelsGCST9047037913.77
1183Omega-3 fatty acid levelsGCST9050205613.76
1184ANPEP/DPP4 ratioGCST9031327313.75
1185FBP1 levelsGCST9046919513.73
1186Cholesteryl ester (16:2) levelsGCST9002523813.70
1187Cholesterol to total lipids in large LDL percentage (UKB data field 23615)GCST9026971213.70
1188CDH3/TNFRSF21 ratioGCST9031395313.70
1189CPM levelsGCST9024059813.68
1190F9 levelsGCST9046917213.67
1191IL1RN levelsGCST9046957613.67
1192ExotropiaGCST9057273713.67
1193CCDC80/CCL27 ratioGCST9031366913.66
1194Cholesterol in IDLGCST9049750113.65
1195Cholesteryl esters in very large VLDLGCST9050055213.64
1196Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050109113.62
1197Concentration of medium LDL particlesGCST9049881913.62
1198CRADD/MAP4K5 ratioGCST9031424013.61
1199DTI autoptx L3 unc r tractGCST9038521913.60
1200Triglycerides in HDLGCST9049746413.60
1201Phospholipid levels in small HDLGCST9009295213.59
1202Skin brightnessGCST9050277713.59
1203Alzheimer's disease (MTAG)GCST9044905813.59
1204SIGLEC8 levelsGCST9047063613.57
1205PSRC1 levelsGCST9047036513.57
1206Physical decline (log-difference score)GCST9056584713.54
1207Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050241113.53
1208DAB2/FKBP5 ratioGCST9031436313.52
1209IFI30 levelsGCST9046950913.50
1210Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST9050075413.50
1211T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 112)GCST9032093113.50
1212LAT2/SERPINB1 ratioGCST9031527913.50
1213Triglycerides | Blood biochemistryUKBB0000086113.48
1214Membranous nephropathyGCST01000613.48
1215SLAMF8 levelsGCST9047065213.46
1216Phosphatidylcholines levels (UKB data field 23437)GCST9026953413.46
1217CEP43/PLXNB3 ratioGCST9031402013.46
1218Alzheimer's disease (MTAG)GCST9044905313.46
1219Triglyceride levels in very small VLDLGCST9009303813.44
1220HLA-DRA levelsGCST9046945813.44
1221Total fatty acid levelsGCST9050271013.43
1222HPCAL1/SERPINB9 ratioGCST9031507913.41
1223FCER2/FCRL1 ratioGCST9031478913.40
1224MMP8 levelsGCST9046992213.40
1225Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)GCST9026958013.38
1226Cholesterol to Total Lipids in Small VLDL percentageGCST9049976413.37
1227Linoleic acid to total fatty acids percentage (UKB data field 23456)GCST9026955313.37
1228CRIP2 levelsGCST9046886413.37
1229PBXIP1 levelsGCST9047016413.37
1230ICAM1/REG1A ratioGCST9031511413.37
1231ITGA5/SELE ratioGCST9031520513.36
1232Cholesterol in Small VLDLGCST9049974613.36
1233Concentration of medium VLDL particlesGCST9049901613.36
1234Phospholipid levels in chylomicrons and extremely large VLDLGCST9009304813.35
1235LAMP1 levelsGCST9046973313.35
1236KYNU levelsGCST9046972213.35
1237Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)GCST9013297313.34
1238HDL cholesterolGCST00075513.34
1239PROK1 levelsGCST9047033613.32
1240Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)GCST9026955113.32
1241Linoleic acid levelsGCST9050229413.29
1242Acute osteomyelitis (PheCode 710.11)GCST9047622213.28
1243Ratio of monounsaturated fatty acids to total fatty acidsGCST9009292913.28
1244BAX/MAX ratioGCST9031346613.27
1245Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050215313.27
1246Acquired toe deformities (PheCode 735.2)GCST9047624913.26
1247Phospholipids in medium LDLGCST9049883113.26
1248DNAJB1/PPME1 ratioGCST9031451013.23
1249DIABLO/DOK2 ratioGCST9031446413.21
1250ALDH1A1/PKLR ratioGCST9031324513.21
1251Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050104513.20
1252Free Cholesterol to Total Lipids in IDL percentageGCST9049757913.19
1253KIAA2013 levelsGCST9046967913.19
1254GFER/VASH1 ratioGCST9031492213.17
1255Concentration of chylomicrons and extremely large VLDL particlesGCST9050101013.17
1256Triglyceride levels (MTAG)GCST9017914913.16
1257CD63 levelsGCST9046864213.16
1258TriglyceridesGCST00221613.15
1259Triglycerides in LDLGCST9049847213.15
1260Left-hemisphere default mode network to putamen white-matter structural connectivityGCST9030276913.14
1261GSN levelsGCST9046940913.14
1262TDRKH/TST ratioGCST9031591313.13
1263high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST9047535213.13
1264CD74/LILRB4 ratioGCST9031389413.11
1265Cholesteryl Esters in Large LDLGCST9049795513.11
1266Docosahexaenoic acid to total fatty acids percentageGCST9050226913.10
1267Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levelsGCST9006055713.08
1268IL15/KLRD1 ratioGCST9031514913.06
1269Total Lipids in VLDLGCST9050023413.05
1270ARSA levelsGCST9046836813.04
1271Monounsaturated fatty acid levelsGCST9050234613.03
1272Monounsaturated fatty acids to total fatty acids percentageGCST9050238513.03
1273QPCT/RNASET2 ratioGCST9031575813.03
1274Total lipids in very small VLDLGCST9050081313.03
1275Omega-6 fatty acid levelsGCST9009293313.02
1276SERPINB6/TXNDC5 ratioGCST9031583213.02
1277Cholesterol to Total Lipids in Small LDL percentageGCST9049956913.02
1278LRRN1 levelsGCST9046980613.01
1279Total triglycerides levelsGCST9050014013.00
1280Triglycerides to Total Lipids in Very Small VLDL percentageGCST9050090013.00
1281Total cholines levelsGCST9049718512.99
1282OtosclerosisFING0000113112.97
1283IDP SWI T2star left caudateGCST9000386512.97
1284Total lipid levels in chylomicrons and extremely large VLDLGCST9050100212.97
1285Triglycerides in HDLGCST9049746712.96
1286PPCDC/RWDD1 ratioGCST9031570412.96
1287Omega-3 fatty acid levelsGCST9050243712.95
1288Concentration of small LDL particlesGCST9049966012.95
1289AGRP levelsGCST9046825612.94
1290C4BPB/ENTPD5 ratioGCST9031355612.94
1291Triglycerides to total lipids ratio in medium HDLGCST9009290312.93
1292PCSK7 levelsGCST9047017612.93
1293Cholesteryl Esters in LDLGCST9049837412.93
1294triglyceride (mean, inv-norm transformed)GCST9047643512.92
1295triglyceride (minimum, inv-norm transformed)GCST9047643712.92
1296LGMN/TIMP1 ratioGCST9031532512.91
1297TGFB1 levelsGCST9027481812.90
1298Total lipids in medium VLDL (UKB data field 23503)GCST9026960012.90
1299CA5A/GRPEL1 ratioGCST9031359012.89
1300CXCL8 levelsGCST9046893412.89
1301Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)GCST9026973712.87
1302HNMT/SETMAR ratioGCST9031506912.85
1303CCL17/THPO ratioGCST9031368912.85
1304IDP dMRI TBSS L1 Genu of corpus callosumGCST9000407712.82
1305Job involves shift work | EmploymentUKBB0000038512.82
1306Phospholipids in large HDLGCST9049784712.82
1307HSPB6 levelsGCST9046949012.82
1308AOC3 levelsGCST9046832212.81
1309Monocyte countGCST9000234112.81
1310Phospholipids to Total Lipids in Medium VLDL percentageGCST9049904312.80
1311Total fatty acid levelsGCST9009298712.79
1312Ulcerative colitis (strict) with PSCFING0000138912.78
1313Free Cholesterol to Total Lipids in Medium VLDL percentageGCST9049898812.77
1314Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050095612.77
1315APOA2 levelsGCST9046833212.76
1316Cereal type - Other (e.g. Cornflakes, Frosties) | DietUKBB0000012512.76
1317Dementia, including avohilmoFING0000039512.76
1318FGFBP2 levelsGCST9046923112.73
1319Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050099212.73
1320VWA1 levelsGCST9047106112.72
1321F11R/TMSB10 ratioGCST9031472912.71
1322Phospholipids to Total Lipids in IDL percentageGCST9049764212.70
1323Triglycerides in LDLGCST9049846912.68
1324Triglycerides in large LDLGCST9049808312.67
1325IDP T1 FIRST right pallidum volumeGCST9000244312.65
1326MSR1/TNFRSF21 ratioGCST9031549412.64
1327Free cholesterol in small LDLGCST9049962012.63
1328CCL14/CST3 ratioGCST9031367912.60
1329Raw carrot likingGCST9009481812.59
1330TNFRSF13B/TNFRSF13C ratioGCST9031593112.59
1331Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST9050079112.59
1332F10 levelsGCST9046916312.56
1333IL6ST/LIFR ratioGCST9031516612.56
1334CFHR4 levelsGCST9046872712.54
1335Linoleic acid levelsGCST9050200412.54
1336CSF1/LTBR ratioGCST9031428712.54
1337Phospholipids to Total Lipids in Small HDL percentageGCST9049950512.53
1338Abdominal subcutaneous adipose tissue volumeGCST9001667212.53
1339OMD levelsGCST9047012312.52
1340CEACAM8/VNN2 ratioGCST9031400512.51
1341OMD/SOST ratioGCST9031558512.50
1342Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050109212.47
1343FGR/LBR ratioGCST9031481412.46
1344EREG/MPI ratioGCST9031470512.45
1345KLRD1 levelsGCST9046971112.45
1346NRCAM/NTRK2 ratioGCST9031555212.44
1347TPK1 levelsGCST9047094312.43
1348Degree of unsaturationGCST9050274612.43
1349ADH4 levelsGCST9046824412.43
1350Concentration of VLDL particlesGCST9050024612.42
1351DFFA/FOXO1 ratioGCST9031445612.42
1352Cholesteryl Esters in Small VLDLGCST9049978212.41
1353Triglycerides in medium LDL (UKB data field 23543)GCST9026964012.41
1354KITLG levelsGCST9001202312.41
1355Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)GCST9026958312.41
1356APRT/CD63 ratioGCST9031333412.41
1357CLEC1B/MGLL ratioGCST9031409712.41
1358Free cholesterol in medium LDLGCST9049876712.40
1359CD302/CD99 ratioGCST9031380512.39
1360high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST9047535612.39
1361CTHRC1 levelsGCST9046890212.39
1362Free Cholesterol to Total Lipids in Small VLDL percentageGCST9049983212.37
1363MEPE/SOST ratioGCST9031542012.37
1364ASAH1 levelsGCST9046837312.37
1365Concentration of small VLDL particles (UKB data field 23509)GCST9026960612.34
1366COL18A1/RARRES2 ratioGCST9031416912.34
1367HCLS1/TMSB10 ratioGCST9031504312.32
1368CLEC1B/SORT1 ratioGCST9031410412.32
1369FHIT/PARK7 ratioGCST9031482112.32
1370Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050092912.31
1371Triglycerides in small VLDLGCST9049991712.31
1372Total lipids in small LDLGCST9049965212.31
1373DCXR/KYNU ratioGCST9031443812.30
1374ACVRL1/TNFRSF10B ratioGCST9031315812.30
1375CLEC1B/SNAP29 ratioGCST9031410312.28
1376ITGB5/VSIR ratioGCST9031523512.28
1377Phosphoglycerides levels (UKB data field 23434)GCST9026953112.24
1378DBNL/DNAJA2 ratioGCST9031441512.23
1379RRM2 levelsGCST9047050112.22
1380Ever worried more than most people would in similar situation | AnxietyUKBB0000022712.20
1381Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050207412.19
1382Cholesterol in Large VLDLGCST9049811912.19
1383NID1 levelsGCST9047004712.17
1384Cholesterol to Total Lipids in IDL percentageGCST9049751812.15
1385IQGAP2/STX4 ratioGCST9031519012.15
1386LBR/MAD1L1 ratioGCST9031529512.13
1387NAGK levelsGCST9046999512.13
1388Concentration of very small VLDL particlesGCST9050082612.13
1389F-capsicum liking (derived food-liking factor)GCST9009472612.12
1390Cholesteryl Esters in VLDLGCST9050021112.12
1391F2R/SPINT2 ratioGCST9031473712.12
1392aseg rh intensity PutamenGCST9000378412.12
1393Cholesterol to Total Lipids in Medium VLDL percentageGCST9049891912.11
1394TNFRSF11B levelsGCST9047090312.11
1395CREG1 levelsGCST9046885712.11
1396MITD1/RHOC ratioGCST9031545312.11
1397End-diastolic bi-ventricular shape (principal component 8)GCST9044848712.10
1398Phosphoglycerides levelsGCST9049925912.09
1399ORM1 levelsGCST9047012912.08
1400Cholesteryl ester levels in large VLDLGCST9009287012.08
1401ATP5IF1/F2R ratioGCST9031338412.06
1402IDP T1 FAST ROIs L ventral striatumGCST9000255912.06
1403DNAJA2/PLXNA4 ratioGCST9031450412.05
1404EREG/ITGB1BP2 ratioGCST9031470312.05
1405MCEE levelsGCST9046987112.04
1406Diacylglycerol_36:3_[M+H-H2O]1+ levelsGCST9006018912.04
1407Cheese intake | DietUKBB0000012712.03
1408BLVRB/CA3 ratioGCST9031352312.01
1409BRK1 levelsGCST9046846911.99
1410VLDL cholesterol levelsGCST9050019611.99
1411Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | MedicationUKBB0000045511.98
1412BGLAP levelsGCST9046844011.98
1413ICAM3/SLAMF7 ratioGCST9031512311.98
1414FAP/THBS4 ratioGCST9031478511.98
1415Triglyceride levels in chylomicrons and extremely large VLDLGCST9013263011.96
1416Myocardial fractal dimension (slice 5)GCST9000029111.95
1417HCLS1/LAT ratioGCST9031504111.95
1418PLAU levelsGCST9047025211.95
1419GOLM2/ITGA5 ratioGCST9031495111.94
1420IDP dMRI TBSS ICVF Cerebral peduncle LGCST9000434211.94
1421triglyceride (maximum, inv-norm transformed)GCST9047643111.94
1422Cholesteryl esters to total lipids ratio in very small VLDLGCST9009303111.93
1423FrecklesGCST00609111.93
1424CLEC1B/DIABLO ratioGCST9031408711.93
1425MDGA1 levelsGCST9046987511.93
1426Ulcerative proctitisFING0000139311.92
1427ART3/RGMB ratioGCST9031336311.91
1428HSPB1/QDPR ratioGCST9031508911.90
1429CKMB levelsGCST9047522111.90
1430ESAM/THPO ratioGCST9031471911.89
1431ALCAM/IL1RL2 ratioGCST9031323811.88
1432Omega-3 fatty acids to total fatty acids percentageGCST9050246311.88
1433Accelerometer-based physical activity measurement (average acceleration)GCST00609911.88
1434CXCL16 levelsGCST9001205911.88
1435Birth year infant mortality ratesGCST9009504711.87
1436Free cholesterol in very small VLDLGCST9050077411.87
1437Noninfective enteritis and colitisFING0000088111.86
1438Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST9049934011.86
1439CLEC1B/MPIG6B ratioGCST9031409811.86
1440Linoleic acid levelsGCST9049830611.84
1441FGL1 levelsGCST9046923511.84
1442Total phospholipid levels in lipoprotein particlesGCST9009299111.83
1443Saturated fatty acids levelsGCST9050219411.83
1444Cholesteryl Esters to Total Lipids in IDL percentageGCST9049754911.82
1445Omega-6 fatty acids levels (UKB data field 23445)GCST9026954211.80
1446RNASE6 levelsGCST9047047911.79
1447DementiaFING0000039111.79
1448IDP dMRI TBSS ICVF Fornix cres+Stria terminalis LGCST9000436611.79
1449KLK6/PTPRN2 ratioGCST9031525611.79
1450CLEC4G/KEL ratioGCST9031411911.79
1451Degree of unsaturationGCST9050223111.78
1452Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050255511.78
1453Monounsaturated fatty acids to total fatty acids percentageGCST9049911111.78
1454Free cholesterol levels in chylomicrons and extremely large VLDLGCST9009304411.77
1455Monounsaturated fatty acids to total fatty acids percentageGCST9049910911.77
1456CRADD/DARS1 ratioGCST9031423411.76
1457IZUMO4 levelsGCST9042379211.75
1458Octadecenedioate (C18:1-DC) levelsGCST9020016511.75
1459LILRB4 levelsGCST9046977811.75
1460CDKN1A/TXLNA ratioGCST9031397911.75
1461Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050256611.74
1462Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levelsGCST9006025411.71
1463ADGRF5 levelsGCST9046823911.70
1464IL1R1/IL1RN ratioGCST9031515811.69
1465Triglycerides in small LDLGCST9049971211.69
1466Docosahexaenoic acid to total fatty acids percentageGCST9049726811.68
1467HPGDS/ITGAV ratioGCST9031508011.67
1468Salty food likingGCST9009482811.66
1469Omega-6 fatty acid levelsGCST9050250211.66
1470LCN2/S100A12 ratioGCST9031530911.66
1471Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST9050094311.65
1472DCBLD2/PLA2G15 ratioGCST9031442811.65
1473IL6 expression at 6 weeks in whole blood upon Bbmix moi30 stimulation in Lyme borreliosisGCST9027578911.64
1474NAGA levelsGCST9046999411.64
1475Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney diseaseGCST9026420711.64
1476CASP3/CRKL ratioGCST9031363111.63
1477ENO2/PLXNA4 ratioGCST9031466511.63
1478LDL cholesterol levelsGCST9049834611.63
1479Left-hemisphere visual network to caudate white-matter structural connectivityGCST9030266311.62
1480F5 levelsGCST9044646611.62
1481MANSC4 levelsGCST9046984811.61
1482Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST9026957811.58
1483Concentration of small VLDL particlesGCST9009297511.58
1484PLA2G15/SMPDL3A ratioGCST9031566311.58
1485Cholesteryl Esters in IDLGCST9049752511.57
1486Principal component-derived dietary pattern 17GCST9013302211.56
1487Total Lipids in LDLGCST9049839611.56
1488CDC37/SNAP29 ratioGCST9031393511.56
1489ADAMTSL2 levelsGCST9046822811.55
1490Cholesterol in IDLGCST9049749511.55
1491IDP dMRI TBSS ICVF Cingulum hippocampus LGCST9000436411.55
1492CD58/IFNGR1 ratioGCST9031384911.54
1493DPP6/NELL2 ratioGCST9031454111.53
1494MYLPF levelsGCST9046998011.53
1495Saturated fatty acids levels (UKB data field 23448)GCST9026954511.53
1496Omega-3 fatty acids to total fatty acids percentageGCST9049915511.52
1497COMP/TGFBI ratioGCST9031419211.52
1498Social trust (aggregated)GCST9031931511.52
1499BAG6/WASF1 ratioGCST9031345211.47
1500Diacylglycerol_36:2_[M+H-H2O]1+ levelsGCST9006019111.46
1501Total fatty acids levels (UKB data field 23442)GCST9026953911.46
1502Left ventricular end diastolic massGCST9026812311.46
1503APP/FKBP1B ratioGCST9031332311.45
1504ITGA6/THPO ratioGCST9031520811.45
1505CPM levelsGCST9046884311.45
1506Phospholipids in VLDLGCST9050026611.44
1507FCGR3B levelsGCST9046920211.44
1508Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T104ECGU00010411.44
1509Phospholipids in VLDL (UKB data field 23412)GCST9026950911.44
1510Polyunsaturated fatty acid levelsGCST9050213411.43
1511EREG/HBEGF ratioGCST9031470211.42
1512Total lipid levels in chylomicrons and extremely large VLDLGCST9009304611.39
1513Total lipids in IDLGCST9049759411.39
1514PDGFB levelsGCST9001201611.37
1515Basophil percentage of granulocytesGCST00463411.37
1516ANGPT1/MPIG6B ratioGCST9031326511.37
1517Triglycerides to total lipids ratio in very small VLDLGCST9009303911.35
1518Free cholesterol in IDLGCST9049756411.34
1519FGF21/LEP ratioGCST9031481011.34
1520Concentration of small VLDL particlesGCST9049986811.32
1521CD99L2/RARRES2 ratioGCST9031392711.32
1522MAD1L1 levelsGCST9046983611.31
1523OSM/TGFA ratioGCST9031559011.31
1524Total cholines levels (UKB data field 23436)GCST9026953311.31
1525CASP3/SERPINE1 ratioGCST9031364311.30
1526Right-hemisphere visual network to pallidum white-matter structural connectivityGCST9030278411.30
1527Free Cholesterol in VLDLGCST9050022111.30
1528DAG1/PLA2G4A ratioGCST9031438011.30
1529CD40LG/EDAR ratioGCST9031381811.30
1530CCN2/SERPINB1 ratioGCST9031371511.29
1531SPOCK1 levelsGCST9047073011.29
1532CD4/LILRB4 ratioGCST9031384311.28
1533OLR1/PLAUR ratioGCST9031558411.28
1534CD27/FCRL5 ratioGCST9031377211.27
1535Total lipid levels in medium VLDLGCST9009292211.27
1536PRL levelsGCST9047033211.27
1537Heart rate variability (standard deviation of normal-to-normal intervals)GCST9028126511.26
1538CALCOCO1/TBC1D5 ratioGCST9031361011.26
1539Omega-3 fatty acid levelsGCST9050206111.25
1540CD84/SDC4 ratioGCST9031391611.25
1541Cholesteryl Esters to Total Lipids in Large LDL percentageGCST9049796711.24
1542Phospholipids in LDLGCST9049843211.23
1543Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T103ECGU00010311.22
1544CNTN2 levelsGCST9046880411.21
1545BSG/TNFRSF4 ratioGCST9031353611.19
1546Gout, strict definitionFING0000058811.19
1547Omega-3 fatty acids to total fatty acids percentageGCST9050246011.19
1548ALKBH3 levelsGCST9061909511.19
1549Volume of right cortico-amygdaloid transition areaGCST9047501811.18
1550ENO2/FXYD5 ratioGCST9031465911.17
1551CRKL/MANF ratioGCST9031426911.16
1552Degree of unsaturationGCST9050223011.15
1553Benign neoplasm: Adrenal glandFING0000016411.13
1554NT5C3A/PRDX5 ratioGCST9031556711.12
1555CHMP1A/RHOC ratioGCST9031405311.11
1556Monounsaturated fatty acid levelsGCST9050203011.10
1557EBAG9/TGFB1 ratioGCST9031457011.10
1558IDP dMRI TBSS ICVF Retrolenticular part of internal capsule LGCST9000434811.09
1559IDP dMRI ProbtrackX ISOVF ifo rGCST9000453811.09
1560CC2D1A/CRADD ratioGCST9031366311.08
1561TriglyceridesGCST9001875511.08
1562PDGFA/USP8 ratioGCST9031562111.06
1563Docosahexaenoic acid to total fatty acids percentageGCST9050199111.06
1564ADAM9 levelsGCST9046822111.06
1565CD300C levelsGCST9046862011.05
1566ERBB2/FURIN ratioGCST9031468611.05
1567DEFA1_DEFA1B/PTGDS ratioGCST9031445511.04
1568CX3CL1/LAYN ratioGCST9031432511.04
1569LTA4H levelsGCST9046981211.04
1570SDC4/SERPINE1 ratioGCST9031581911.03
1571PLIN1/SNCG ratioGCST9031567711.02
1572Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050256711.01
1573CA13/QDPR ratioGCST9031356411.01
1574FGFR4 levelsGCST9046923411.01
1575CALCOCO1/METAP2 ratioGCST9031360611.01
1576Cholesteryl esters to total lipids ratio in small LDLGCST9009295911.00
1577T1 FreeSurfer BA lh BA3a exvivo thicknessGCST9038552111.00
1578Crohn's disease of small intestineFING0000036910.99
1579Neutrophil countGCST9001874810.99
1580HayfeverGCST9046813110.98
1581Saturated fatty acid levelsGCST9009298010.97
1582ACVRL1/TNFRSF9 ratioGCST9031316010.96
1583Polyunsaturated fatty acid levelsGCST9050214210.96
1584LRTM2 levelsGCST9046980810.95
1585PDGFA/SNAP23 ratioGCST9031561910.95
1586BPIFB1/GLRX ratioGCST9031353010.94
1587STC2 levelsGCST9047076210.89
1588ENO2/SULT1A1 ratioGCST9031466910.88
1589Triglyceride levels in chylomicrons and extremely large VLDLGCST9009305010.88
1590CD19 on IgD- CD27- B cellGCST9000173210.87
1591Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)FING0000086610.87
1592MCTS1 levelsGCST9046987410.87
1593APOB levelsGCST9049713710.86
1594Omega-3 fatty acid levelsGCST9050242410.85
1595Linoleic acid to total fatty acids percentageGCST9050202510.85
1596Dimethylglycine levelsGCST9020042410.85
1597DPP6/SEZ6L ratioGCST9031454410.84
1598Cholesteryl esters to total lipids ratio in medium HDLGCST9009289510.81
1599IDP dMRI TBSS ICVF Retrolenticular part of internal capsule RGCST9000434710.80
1600Rotator cuff syndromeFING0000127010.80
1601ASRGL1 levelsGCST9046837910.79
1602NFKBIE levelsGCST9047003910.79
1603Conditional arithmetic | Fluid intelligence / reasoningUKBB0000014510.78
1604Omega-6 fatty acids levelsGCST9049917010.78
1605Cholesterol to total lipids ratio in very small VLDLGCST9009302910.78
1606IL18R1 levelsGCST9046956510.78
1607IDP dMRI TBSS L1 Corticospinal tract RGCST9000408110.78
1608X-13671 levelsGCST9024382910.76
1609Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)GCST9026971410.76
1610CLEC1B/PLXNA4 ratioGCST9031410010.75
1611Phospholipids to total lipids ratio in chylomicrons and extremely large VLDLGCST9009304910.75
1612BCAN/NCAN ratioGCST9031348110.75
1613Phospholipids to Total Lipids in Small VLDL percentageGCST9049990210.75
1614Alanine transaminase (ALT, maximum, inv-norm transformed)GCST9047510910.74
1615HDL x low social support interaction (2df test)GCST9057066910.73
1616CHAD levelsGCST9046873710.72
1617Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)GCST9026957910.72
1618Monocyte countGCST9001874710.71
1619FNDC1 levelsGCST9046925610.71
1620CNTN1 levelsGCST9046880310.70
1621Free cholesterol to total lipids ratio in IDLGCST9009283610.70
1622OSCAR/TNFRSF14 ratioGCST9031558810.69
1623LGALS1/LGALS8 ratioGCST9031531410.69
1624Heart rate variability (corrected standard deviation of normal-to-normal intervals)GCST9028126610.69
1625ANGPT1/CPXM1 ratioGCST9031326210.69
1626FABP4/SNCG ratioGCST9031475910.68
1627CST3/RARRES2 ratioGCST9031429510.67
1628DPT levelsGCST9046903610.67
1629ARSA/CD164 ratioGCST9031335110.66
1630Triglyceride levels in very large HDLGCST9013263610.65
1631Cholesteryl esters to total lipids ratio in very large HDLGCST9009300710.65
1632CLEC1B/DAB2 ratioGCST9031408610.64
1633Cholesteryl Esters in Small HDLGCST9049938610.64
1634Cholesterol to Total Lipids in Large LDL percentageGCST9049793810.64
1635RARRES2 levelsGCST9047042810.64
1636CD80 levelsGCST9046865010.64
1637SPP1 levelsGCST9047073310.64
1638KITLG levelsGCST9046969110.64
1639FracturesGCST00698010.63
1640NTRK3 levelsGCST9047009810.63
1641DKK1/VTA1 ratioGCST9031448510.63
1642Modified Stumvoll Insulin Sensitivity IndexGCST9026757410.63
1643Total phospholipids in lipoprotein particles (UKB data field 23411)GCST9026950810.62
1644CCL11/CCL13 ratioGCST9031367110.61
1645Cholesterol levels (UKB data field 30690)GCST9046806610.61
1646Osteomyelitis (PheCode 710.1)GCST9047622110.61
1647Hard cheese likingGCST9009477810.60
1648FCGR2A levelsGCST9046920010.59
1649LMNB2 levelsGCST9046978210.59
1650Gestational thrombocytopeniaGCST9030223410.59
1651Chronic nephritic syndromeFING0000029510.58
1652Free testosterone levelsGCST9023982510.56
1653Triacylglycerol (54:1) [NL-18:1] levelsGCST9002456310.56
1654Polyunsaturated fatty acid levelsGCST9009293910.55
1655DIABLO/PDGFB ratioGCST9031446810.55
1656HBEGF/LAT2 ratioGCST9031503210.55
1657S100A11/SERPINB8 ratioGCST9031579910.53
1658Cholesteryl esters to total lipids ratio in medium VLDLGCST9009291910.53
1659DBNL/HSPA1A ratioGCST9031441810.53
1660PLXNA4/VASH1 ratioGCST9031569110.53
1661ICOSLG levelsGCST9046950310.53
1662PLA2G10 levelsGCST9047024410.51
1663CDC37/PPP1R12A ratioGCST9031393410.51
1664EREG/TIMP3 ratioGCST9031470810.50
1665BACH1/NFATC1 ratioGCST9031344410.49
1666Single spontaneous deliveryFING0000130710.49
1667white blood cell count (WBC, maximum, inv-norm transformed)GCST9047645110.49
1668CD27/TNFRSF9 ratioGCST9031377810.49
1669GZMA/TNFRSF8 ratioGCST9031501410.49
1670BCAN/KLK6 ratioGCST9031347910.48
1671SERPINE1/VASH1 ratioGCST9031583610.47
1672CEP43/TIA1 ratioGCST9031402110.46
1673Polyunsaturated fatty acid levelsGCST9050261810.46
1674CRLF1 levelsGCST9046886810.45
1675BLMH levelsGCST9046844710.45
1676UBA9475 sp002161235 abundance in stoolGCST9003263510.45
1677ADH4/CA5A ratioGCST9031318910.45
1678Total lipids in large LDLGCST9049801110.45
1679Linoleic acid to total fatty acids percentageGCST9050233710.44
1680Neutrophil countGCST9000235210.43
1681Total protein levelsGCST9046810510.43
1682Polycystic ovarian syndrome, broad definitionFING0000118310.43
1683TGFBI levelsGCST9047084510.40
1684DCBLD2 levelsGCST9046895210.40
1685Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9049928810.39
16863-Hydroxybutyrate levelsGCST9009281110.38
1687FOXO1/NUB1 ratioGCST9031487410.38
1688Plasma pregnenetriol disulfate* levels in chronic kidney diseaseGCST9026586410.38
1689White blood cell countGCST9000237510.38
1690TMSB10/TREML2 ratioGCST9031592310.37
1691COLEC12/LTBR ratioGCST9031418210.37
1692Total cholesterol minus HDL-C levelsGCST9049912910.37
1693DKK1/LGALS8 ratioGCST9031447210.36
1694ANXA3/ENO2 ratioGCST9031328110.36
1695Total lipids in small VLDL (UKB data field 23510)GCST9026960710.36
1696CALCOCO1/DCTN1 ratioGCST9031360010.36
1697MRPL33 levelsGCST9061798610.36
1698SERPIND1 levelsGCST9047059510.35
1699Phospholipids to total lipids ratio in medium HDLGCST9009290110.34
1700APBB1IP levelsGCST9046832710.34
1701IL2RA levelsGCST9046958510.33
1702ASAH2 levelsGCST9046837410.33
1703Clinical LDL cholesterol levelsGCST9049721910.32
1704Concentration of LDL particlesGCST9049841310.31
1705CLEC1A/TNFRSF1A ratioGCST9031408510.31
1706PLG levelsGCST9047025710.31
1707Posterior diffusion tensor imaging along the perivascular space indexGCST9045554510.31
1708TriglyceridesGCST00075810.30
1709CFH levelsGCST9046872910.29
1710DUSP3 levelsGCST9046905310.29
1711FABP3 levelsGCST9046917510.29
1712Total lipid levels in small VLDLGCST9009297410.27
1713ADGRE5/SEMA7A ratioGCST9031318310.27
1714Left ventricular end systole anterolateral wall thicknessGCST9027851110.26
1715Triglyceride levels in HDLGCST9009282910.26
1716Docosahexaenoic acid to total fatty acids percentageGCST9050199910.26
1717CD86 levelsGCST9046865410.25
1718Whole grain cereal likingGCST9009486910.25
1719Cholesterol in Small LDLGCST9049955910.25
1720Triglycerides in medium LDLGCST9049887010.25
1721Type 2 diabetesGCST9008607210.25
1722Total cholesterol levelsGCST9023967510.24
1723CCL11 levelsGCST9046856410.24
1724CCL17 levelsGCST9046856910.23
1725IDP dMRI TBSS OD Genu of corpus callosumGCST9000440410.23
1726Maximum heart rate during fitness test | ECG during exerciseUKBB0000043110.22
1727CASP8/SEPTIN9 ratioGCST9031365810.22
1728BSG/CKAP4 ratioGCST9031353110.22
1729Phospholipids to Total Lipids in Large LDL percentageGCST9049807110.21
1730Alkylphosphatidylcholine (O-32:1) levelsGCST9002492310.20
1731EPPK1 levelsGCST9046913710.20
1732CASP3/PDGFB ratioGCST9031363810.19
1733MMP1/SERPINB6 ratioGCST9031546210.19
1734Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050214710.18
1735Rubneribacter sp002159915 abundance in stoolGCST9003254110.18
1736EBAG9/HBEGF ratioGCST9031456510.18
1737MFAP4 levelsGCST9046989810.17
1738APBB1IP/NADK ratioGCST9031329810.17
1739Phospholipid levels in VLDLGCST9009300110.17
1740Tea without sugar likingGCST9009485810.17
1741DAB2/TBL1X ratioGCST9031436810.16
1742CA4/SELE ratioGCST9031358710.16
1743Triglycerides to Total Lipids in Large LDL percentageGCST9049810110.15
1744IDP dMRI TBSS L2 Retrolenticular part of internal capsule RGCST9000414310.14
1745FUS levelsGCST9046927810.14
1746ConjunctivitisFING0000034610.13
1747IDP SWI T2star left pallidumGCST9000386910.13
1748COMP/ICAM1 ratioGCST9031418910.12
1749Free Cholesterol to Total Lipids in Medium LDL percentageGCST9049878310.10
1750TNFSF10 levelsGCST9047091710.10
1751Free cholesterol to total lipids ratio in very large VLDLGCST9009302110.10
1752CCN3/FAP ratioGCST9031372110.08
1753TMEM106A levelsGCST9047088610.07
1754DCTN1/TRIAP1 ratioGCST9031443410.07
1755Triglycerides to total lipids in medium HDL percentage (UKB data field 23643)GCST9026974010.06
1756CLEC4G/MERTK ratioGCST9031412110.06
1757Positional arithmetic | Fluid intelligence / reasoningUKBB0000065410.05
1758CCN1 levelsGCST9046858710.04
1759CCL20 levelsGCST9046857210.04
1760CRADD/STAMBP ratioGCST9031424410.03
1761SEZ6L2 levelsGCST9047060610.03
1762Phospholipids to Total Lipids in Small LDL percentageGCST9049970010.02
1763Left-hemisphere visual network to accumbens white-matter structural connectivityGCST9030266810.02
1764CSF1/SEMA3F ratioGCST9031428810.02
1765GART levelsGCST9046930310.02
1766SETMAR levelsGCST9047060510.01
1767BST2/CXADR ratioGCST9031353810.00
1768Triglycerides x anxiety interaction (2df test)GCST905706779.98
1769PSAP levelsGCST904265869.98
1770IL17RB levelsGCST904695639.98
1771KLKB1 levelsGCST904697089.97
1772Phospholipids to total lipids in medium HDL percentage (UKB data field 23639)GCST902697369.97
1773EIF4G1/NFATC1 ratioGCST903146379.96
1774Omega-3 fatty acids to total fatty acids percentageGCST905020889.96
1775KYNU/SCLY ratioGCST903152659.93
1776GP1BA/SIAE ratioGCST903149599.93
1777Cardiovascular diseaseGCST900860579.93
1778CD22 levelsGCST904686109.93
1779Certain disorders involving the immune mechanismFING000002649.92
1780MMP3 levelsGCST904699209.92
1781MOG/SEZ6L ratioGCST903154779.92
1782Witnessed sudden violent death | Traumatic eventsUKBB000009179.91
1783DBNL/PDGFB ratioGCST903144229.90
1784TNFSF14 levelsGCST904709229.89
1785Free Cholesterol to Total Lipids in Large LDL percentageGCST904980009.89
1786Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | MedicationUKBB000004569.88
1787Cholesteryl esters to total lipids ratio in large VLDLGCST900928719.87
1788Other degenerative diseases of the nervous systemFING000009949.87
1789Triglycerides to Total Lipids in Large HDL percentageGCST904979069.87
1790Cholesterol to total lipids ratio in medium VLDLGCST900929179.85
1791FGFBP3 levelsGCST904692329.83
1792SIGLEC7 levelsGCST904706359.83
1793PAMR1 levelsGCST904701559.83
1794Sphingomyelin_42:2_[M+OAc]1- levelsGCST900605079.83
1795Physical activity (Total log acceleration)GCST900614089.82
1796NECTIN2/TNFRSF1A ratioGCST903155329.82
1797Polyunsaturated fatty acids levels (UKB data field 23446)GCST902695439.82
1798Triglycerides to total lipids ratio in chylomicrons and extremely large VLDLGCST900930519.82
1799Triacylglycerol_46:4_[M+NH4]1+ levelsGCST900603629.81
1800LCN2/RETN ratioGCST903153089.81
1801CD22/FCRL1 ratioGCST903137579.81
1802NPY/SMOC1 ratioGCST903155519.80
1803ITGB1/REG1A ratioGCST903152289.79
1804Volume of right medial nucleusGCST904750459.79
1805GFAP levelsGCST904693259.78
1806Free Cholesterol to Total Lipids in Very Large HDL percentageGCST905003979.78
1807IBD (strict) with PSCFING000006579.77
1808SLC39A5 levelsGCST904706619.76
1809LILRB1 levelsGCST904697769.76
1810Pain type(s) experienced in last month - Pain all over the body | PainUKBB000006329.75
1811IDP dMRI ProbtrackX FA cgc rGCST900039309.75
1812Skin luminanceGCST903202579.73
1813PI16 levelsGCST904702299.73
1814IDP T1 SIENAX white unnormalised volumeGCST900024339.72
1815Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)GCST902695849.70
1816SSC-A on plasmacytoid Dendritic CellGCST900020729.69
1817Abdominal subcutaneous adipose tissueGCST902673479.69
1818COLEC12/NBL1 ratioGCST903141839.68
1819Visceral adipose tissueGCST902673579.68
1820IL32 levelsGCST904695919.67
1821CALCOCO1/CASP8 ratioGCST903135979.66
1822Mineral and other dietary supplements - Calcium | MedicationUKBB000004719.66
1823SRPX levelsGCST904707449.65
1824Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023999.65
1825Triglycerides in HDL (UKB data field 23410)GCST902695079.65
1826ERBIN/SNAP29 ratioGCST903146979.64
1827CD14 levelsGCST904685989.63
1828SMAD5 levelsGCST904706789.63
1829aparc-DKTatlas rh area insulaGCST900032969.60
1830IDP dMRI ProbtrackX ICVF ifo lGCST900043879.60
1831Polyunsaturated fatty acids to total fatty acids percentageGCST905026489.60
1832Acute appendicitis, with complicationsFING000000199.59
1833Triglycerides to Total Lipids in Large LDL percentageGCST904980929.59
1834IDP dMRI TBSS FA Retrolenticular part of internal capsule RGCST900038979.58
1835Left-hemisphere visual network to pallidum white-matter structural connectivityGCST903026659.57
1836Concentration of large LDL particlesGCST904980379.57
1837PALM3 levelsGCST904701539.57
1838Free cholesterol in VLDL (UKB data field 23420)GCST902695179.56
1839SOST/SPP1 ratioGCST903158719.56
1840SPARC/TJAP1 ratioGCST903158739.56
1841CTSZ/SMPDL3A ratioGCST903143229.56
1842Triglycerides in very large HDL (UKB data field 23557)GCST902696549.55
1843CDKN1A/FOXO1 ratioGCST903139709.55
1844KLK8 levelsGCST902416809.55
1845Ratio of linoleic acid to total fatty acidsGCST900928819.55
1846Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020759.54
1847IDP dMRI ProbtrackX ICVF ilf rGCST900043909.54
1848Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)GCST902695559.53
1849FCER1A levelsGCST904691989.53
1850IDP dMRI TBSS ICVF Sagittal stratum RGCST900043579.53
1851SIAE levelsGCST904706299.53
1852KIT levelsGCST904696929.53
1853Triacylglycerol (54:2) [NL-18:0] levelsGCST900251759.52
1854Cholesterol, totalGCST0007609.52
1855Free cholesterol levels in very large HDLGCST901326809.50
1856Irritable bowel syndromeGCST902439589.50
1857CXCL13 levelsGCST904689269.50
1858ASGR1 levelsGCST904683759.49
1859CD69/F2R ratioGCST903138779.49
1860CD226 levelsGCST904686099.49
1861Alkylphosphatidylcholine (O-34:1) levelsGCST900255519.48
1862Triglycerides to Total Lipids in Very Large HDL percentageGCST905005089.48
1863LCN2/PRTN3 ratioGCST903153079.47
1864Non-HDL cholesterol levelsGCST902396699.45
1865GBA1 levelsGCST904232629.44
1866CA4/TNFSF12 ratioGCST903135899.44
1867SNCA levelsGCST902402589.44
1868TMEM25 levelsGCST904708889.43
1869Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10)GCST900426789.43
1870Free cholesterol to total lipids ratio in very small VLDLGCST900930339.42
1871SHBG levelsGCST905033159.42
1872CCL3 levelsGCST904685829.41
1873Triglycerides to Total Lipids in IDL percentageGCST904976769.41
1874CRADD/EREG ratioGCST903142369.41
1875GFRA3 levelsGCST904693309.40
1876Benign neoplasm: ChoroidFING000001709.40
1877CXCL11/SDC4 ratioGCST903143369.39
1878USP8/WASF1 ratioGCST903159449.39
1879PDGFB/SDC4 ratioGCST903156269.38
1880Carnitine levelsGCST902399919.38
1881CLEC1B/ITGB5 ratioGCST903140949.38
1882LEPR/NRCAM ratioGCST903153129.37
1883C1S levelsGCST904684949.36
1884Triglycerides in very small VLDL (UKB data field 23522)GCST902696199.36
1885NID1/SORT1 ratioGCST903155429.35
1886SORT1 levelsGCST904707109.35
1887FCRL5/TNFRSF13B ratioGCST903148059.34
1888CRTAC1 levelsGCST904688709.34
1889GFRA1 levelsGCST904693289.34
1890Total Phosphatidylethanolamine levelsGCST900252079.33
1891Lung adenocarcinomaGCST0047449.32
1892Diseases of middle ear and mastoidFING000004279.31
1893Facial pigmentation measurement (UV light)GCST900022839.31
1894CANT1/HSPB1 ratioGCST903136179.30
1895HBEGF/PLXNA4 ratioGCST903150369.29
1896KIFBP/TBC1D23 ratioGCST903152509.29
1897Omega-3 fatty acids to total fatty acids percentageGCST904991639.29
1898CPA4 levelsGCST904688389.29
1899KIR2DL2 levelsGCST904696849.28
1900Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027329.28
1901Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005699.27
1902LY6D/PLA2G10 ratioGCST903153459.26
1903LPO levelsGCST904697899.26
1904F-fruit liking (derived food-liking factor)GCST900947679.26
1905lymphocyte (fraction, mean, inv-norm transformed)GCST904754359.26
1906X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levelsGCST902436199.26
1907Free Cholesterol in LDLGCST904983869.25
1908MAX/TDRKH ratioGCST903154069.25
1909FADD/NFATC1 ratioGCST903147719.25
1910Triglycerides to Total Lipids in Medium HDL percentageGCST904986829.25
1911Saturated fatty acids levelsGCST905021869.24
1912Total lipid levels in lipoprotein particlesGCST900929899.23
1913ATOX1/SPARC ratioGCST903133759.23
1914CRHBP levelsGCST904688609.23
1915EGLN1/FOXO1 ratioGCST903146169.22
1916IDI2 levelsGCST904695059.22
1917VWC2 levelsGCST904710649.21
1918IDP dMRI ProbtrackX ICVF ilf lGCST900043899.21
1919CA5A/GSTA1 ratioGCST903135919.20
1920Cholesterol | Blood biochemistryUKBB000001349.19
1921CXCL11/CXCL13 ratioGCST903143339.19
1922RECK levelsGCST904704459.19
1923IL1RN levelsGCST900120049.18
1924IDP T1 SIENAX white normalised volumeGCST900024329.18
1925FCGR2B levelsGCST904692019.17
1926Crohn disease (strict definition, require KELA, min 2 HDR)FING000003669.17
1927Free cholesterol in large HDLGCST904977809.16
1928KLK11 levelsGCST904696979.15
1929Triglyceride levels in LDLGCST900928909.13
1930Average diameter for HDL particlesGCST901327029.13
1931IDP dMRI ProbtrackX L1 cgc rGCST900042519.13
1932EDAR/TNFSF12 ratioGCST903145919.13
1933DNMBP/TJAP1 ratioGCST903145219.12
1934DIABLO/MITD1 ratioGCST903144679.11
1935Docosahexaenoic acid levelsGCST904972529.11
1936DTI autoptx L2 cgc r tractGCST903851719.10
1937CD83/IL12A_IL12B ratioGCST903139059.10
1938C19ORF12 levelsGCST904684839.10
1939Sardines likingGCST900948309.09
1940OtosclerosisGCST901295759.09
1941IL6ST/LEPR ratioGCST903151659.08
1942Alzheimer's disease (MTAG)GCST904490629.08
1943HSPG2/SMOC2 ratioGCST903150939.06
1944CD84/CDKN1A ratioGCST903139099.06
1945Total fatty acid levelsGCST905022129.05
1946GLB1 levelsGCST904693559.04
1947SERPINA9 levelsGCST904705889.04
1948Triglycerides to Total Lipids in Medium HDL percentageGCST904986899.03
1949Citrate levelsGCST904972069.03
1950Sphingomyelin_40:0_[M+H]1+ levelsGCST900603649.03
1951Coffee difference likingGCST900947389.03
1952Polyunsaturated fatty acid levelsGCST905021409.02
1953Acetoacetate levelsGCST900928049.01
1954Total protein levelsUKBB000008269.01
1955Triglycerides to Total Lipids in IDL percentageGCST904976829.01
1956MDH1 levelsGCST904698769.01
1957Omega-6 fatty acid levelsGCST905020959.00
1958CDH17 levelsGCST904686699.00
1959Polymyalgia rheumaticaFING000011889.00
1960Other strabismusFING000011148.99
1961DCTN1/FXN ratioGCST903144308.98
1962Triglycerides in IDLGCST904976718.98
1963lymphocyte (fraction, maximum, inv-norm transformed)GCST904754328.98
1964FCAR levelsGCST904691978.96
1965Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211)GCST900435528.96
1966aseg rh intensity CaudateGCST900037838.95
1967Crohn's disease of large intestineFING000003688.94
1968CCL15/CCL23 ratioGCST903136818.92
1969IDP SWI T2star right caudateGCST900038668.92
1970ASGR1/DCBLD2 ratioGCST903133648.89
1971CRADD/HSPA1A ratioGCST903142398.88
1972Barrett's esophagusGCST0037388.88
1973IDP T1 FAST ROIs R cerebellum VGCST900025658.87
1974NCAN levelsGCST904700058.87
1975COL1A1 levelsGCST904688138.87
1976F-burn/spicy liking (derived food-liking factor)GCST900947168.87
1977CD22/FCER2 ratioGCST903137568.86
1978CEP43 levelsGCST904687158.84
1979Docosahexaenoic acid levelsGCST905019868.84
1980Mean bone marrow fat fraction of thoracic vertebrae 8-12GCST906523858.83
1981IDP dMRI ProbtrackX ICVF ifo rGCST900043888.83
1982Free cholesterol to total lipids in large HDL percentage (UKB data field 23637)GCST902697348.82
1983LGALS3 levelsGCST904697618.82
1984Omega-3 fatty acid levelsGCST905024258.81
1985Right-hemisphere limbic network to hippocampus white-matter structural connectivityGCST903028318.81
1986BAG6/USP8 ratioGCST903134518.81
1987MYL3 levelsGCST904699778.79
1988Myocardial fractal dimension (slice 6)GCST900002928.79
19891-stearoyl-2-linoleoyl-GPI (18:0/18:2) levelsGCST902000678.78
1990LY6G6C levelsGCST902418308.78
1991Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T230ECGU0002308.77
1992Docosahexaenoic acid levelsGCST905022428.75
1993NOS3 levelsGCST904700648.75
1994HSPG2/VASN ratioGCST903150948.74
1995B4GALT1/SPON2 ratioGCST903134348.74
1996APP/TMSB10 ratioGCST903133328.74
1997White blood cell countGCST900187588.73
1998DCTN6 levelsGCST904689608.73
1999CD244 levelsGCST902747718.72
2000Phospholipids to total lipids in very large HDL percentage (UKB data field 23629)GCST902697268.72